A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo
- PDF / 4,656,183 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 35 Downloads / 221 Views
RAPID COMMUNICATION
A high‑throughput detection method for the clonality of Human T‑cell leukemia virus type‑1‑infected cells in vivo Masumichi Saito1 · Hiroo Hasegawa2,3 · Shunsuke Yamauchi2 · So Nakagawa4,5 · Daisuke Sasaki2 · Naganori Nao6 · Michikazu Tanio1 · Yusaku Wada7 · Takahiro Matsudaira7 · Haruka Momose1 · Madoka Kuramitsu1 · Makoto Yamagishi8 · Makoto Nakashima8 · Shingo Nakahata9 · Hidekatsu Iha10 · Masao Ogata11 · Yoshitaka Imaizumi12 · Kaoru Uchimaru8 · Kazuhiro Morishita9 · Toshiki Watanabe13 · Yasushi Miyazaki12,14 · Katsunori Yanagihara2,3 Received: 16 March 2020 / Revised: 23 June 2020 / Accepted: 29 June 2020 © Japanese Society of Hematology 2020
Abstract Approximately 10–20 million of Human T-cell leukemia virus type-1 (HTLV-1)-infected carriers have been previously reported, and approximately 5% of these carriers develop adult T-cell leukemia/lymphoma (ATL) with a characteristic poor prognosis. In Japan, Southern blotting has long been routinely performed for detection of clonally expanded ATL cells in vivo, and as a confirmatory diagnostic test for ATL. However, alternative methods to Southern blotting, such as sensitive, quantitative, and rapid analytical methods, are currently required in clinical practice. In this study, we developed a highthroughput method called rapid amplification of integration site (RAIS) that could amplify HTLV-1-integrated fragments within 4 h and detect the integration sites in > 0.16% of infected cells. Furthermore, we established a novel quantification method for HTLV-1 clonality using Sanger sequencing with RAIS products, and the validity of the quantification method was confirmed by comparing it with next-generation sequencing in terms of the clonality. Thus, we believe that RAIS has a high potential for use as an alternative routine molecular confirmatory test for the clonality analysis of HTLV-1-infected cells. Keywords HTLV-1 · ATL · RAIS (rapid amplification of integration site)
Introduction Human T-cell leukemia virus type-1 (HTLV-1) primarily infects CD4-positive T-cells, and the provirus integrates into the host genome. A subset of the infected cells transforms to malignant T-cells after a long period, and clonal expansion stimulates the pathogenesis of adult T-cell leukemia/lymphoma (ATL). To assess the clonal expansion of Masumichi Saito, Hiroo Hasegawa and Shunsuke Yamauchi contributed equally to this work. Electronic supplementary material The online version of this article (https://doi.org/10.1007/s12185-020-02935-5) contains supplementary material, which is available to authorized users. * Masumichi Saito [email protected] * Hiroo Hasegawa hhase@nagasaki‑u.ac.jp Extended author information available on the last page of the article
HTLV-1-infected malignant cells, Southern blotting has long been routinely performed as a confirmatory diagnostic test for ATL in Japan. However, this method has several considerations, including the amount of patient sample (blood DNA) required, technical skill, sensitivity, cost, and time. Alternative method
Data Loading...
